Genetic Variants (rs869109213 and rs2070744) Of the eNOS Gene and BglII in the α2 Subunit of the α2β1 Integrin Gene and Diabetic Retinopathy.

Genetic Variants (rs869109213 and rs2070744) Of the eNOS Gene and BglII in the α2 Subunit of the α2β1 Integrin Gene and Diabetic Retinopathy. Semin Ophthalmol. 2019 Aug 15;:1 Authors: Joob B, Wiwanitkit V PMID: 31416385 [PubMed - as supplied by publisher]
Source: Seminars in Ophthalmology - Category: Opthalmology Tags: Semin Ophthalmol Source Type: research

Related Links:

Abstract: The US industrial revolution led to a significant increase in the amount of dietary sugar consumed annually. The impact has become a public health crisis over the past several decades. The consequences are seen in the dramatic rise in rates of obesity, type 2 diabetes mellitus, and cardiovascular disease.
Source: The Nurse Practitioner - Category: Nursing Tags: Feature: SUGAR CONSUMPTION Source Type: research
The drug, Rybelsus (semaglutide) is the first pill in a class of drugs called glucagon-like peptide (GLP-1) approved for use in the United States. Before Rybelsus, the drug had to be injected.
Source: WebMD Health - Category: Consumer Health News Source Type: news
The panel also recommends approval of Qtrilmet, a fixed-dose combination of metformin hydrochloride/saxagliptin/dapagliflozin for treatment of type 2 diabetes.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s): Elizabeth Sellers
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7Author(s):
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Semaglutide is the first oral glucagon-like peptide-1 receptor agonist. Previously, drugs of this class were available only as injectables. The approval is expected to increase uptake.FDA Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news
When it came to the cause of death, vitamin D levels were most clearly linked to deaths from diabetes complications.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Diabetes | Endocrinology | Genetics | Opthalmology